Capital Flow Monitor · Sponsors · CIK 2011514
Anteris Technologies Global Corp.
Toowong Tower, Level 3, Suite 302, Toowong, QLD, C3, 4066 · 61-7-3152-3200
Biotechnology · Corporation· inc. DELAWARE true 2024
Fit score
—
Offering
$11.5M
Sold
$11.5M
% sold
100.0%
Investors
9
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2025-11-07 | D ·current | 506(b) | $11.5M | $11.5M | 100.0% | 9 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Wayne Paterson — Director / Executive Officer, Toowong, QLD, C3
- Matthew McDonnell — Executive Officer, Toowong, QLD, C3
- David St Denis — Director / Executive Officer, Toowong, QLD, C3
-
John Seaberg — Director, Toowong, QLD, C3
1 other raise
- Preceptis Medical, Inc. $2.6M of $6.9M · 37.1%
- Stephen Denaro — Director, Toowong, QLD, C3
-
David Roberts — Director, Toowong, QLD, C3
1 other raise
- SOPERTON BANCSHARES Inc $5.0M of $5.0M · 100.0%
- Greg Moss — Director, Toowong, QLD, C3
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.